COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
3.750
+0.190 (5.34%)
Nov 4, 2024, 4:00 PM EST - Market closed

COSCIENS Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
27.834.0250.6165.324.277.84
Upgrade
Cash & Short-Term Investments
27.834.0250.6165.324.277.84
Upgrade
Cash Growth
-34.09%-32.79%-22.49%169.05%209.66%-45.99%
Upgrade
Accounts Receivable
1.240.070.40.881.190.21
Upgrade
Other Receivables
0.120.281.762.81.090.45
Upgrade
Receivables
1.360.342.163.682.280.66
Upgrade
Inventory
3.060.070.230.070.021.38
Upgrade
Prepaid Expenses
00.250.430.421.020.79
Upgrade
Other Current Assets
0.991.692.061.350.020.25
Upgrade
Total Current Assets
33.2136.3755.4970.8227.6110.91
Upgrade
Property, Plant & Equipment
11.50.320.220.190.180.62
Upgrade
Goodwill
---8.138.828.05
Upgrade
Other Intangible Assets
3.34--0.630.060.04
Upgrade
Long-Term Deferred Tax Assets
0.95-----
Upgrade
Other Long-Term Assets
1.050.330.320.340.340.36
Upgrade
Total Assets
50.0537.0256.0380.137.0119.98
Upgrade
Accounts Payable
3.591.872.040.931.191.09
Upgrade
Accrued Expenses
2.261.761.791.741.011.06
Upgrade
Short-Term Debt
-----0
Upgrade
Current Portion of Leases
0.410.160.110.130.140.65
Upgrade
Current Income Taxes Payable
0.110.110.110.120.121.45
Upgrade
Current Unearned Revenue
0.10.222.954.822.190.99
Upgrade
Other Current Liabilities
3.450.430.050.030.090.42
Upgrade
Total Current Liabilities
9.94.547.047.774.745.66
Upgrade
Long-Term Leases
1.280.120.070.030.050.26
Upgrade
Long-Term Unearned Revenue
1.611.541.791.593.290.19
Upgrade
Other Long-Term Liabilities
--0.190.240.282.56
Upgrade
Total Liabilities
23.8218.8220.2527.1223.7922.44
Upgrade
Common Stock
22293.41293.41293.41235.01224.53
Upgrade
Additional Paid-In Capital
-90.7190.33---
Upgrade
Retained Earnings
1.53-369.83-352.08-334.62-322.66-316.89
Upgrade
Comprehensive Income & Other
2.693.914.1294.2100.8689.9
Upgrade
Shareholders' Equity
26.2318.235.7852.9913.21-2.46
Upgrade
Total Liabilities & Equity
50.0537.0256.0380.137.0119.98
Upgrade
Total Debt
1.690.280.180.160.180.91
Upgrade
Net Cash (Debt)
26.1233.7450.4365.1424.096.93
Upgrade
Net Cash Growth
-37.75%-33.10%-22.58%170.43%247.53%-49.68%
Upgrade
Net Cash Per Share
19.9827.7941.5456.6858.6339.62
Upgrade
Filing Date Shares Outstanding
3.121.211.211.211.210.23
Upgrade
Total Common Shares Outstanding
3.061.211.211.210.630.2
Upgrade
Working Capital
23.3131.8348.4463.0522.875.25
Upgrade
Book Value Per Share
8.5714.9929.4743.6521.08-12.32
Upgrade
Tangible Book Value
22.8918.235.7844.234.34-10.55
Upgrade
Tangible Book Value Per Share
7.4814.9929.4736.446.92-52.78
Upgrade
Machinery
12.430.490.450.470.550.74
Upgrade
Leasehold Improvements
6.48----0.03
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.